Trial Profile
A study assessing pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2018
Price :
$35
*
At a glance
- Drugs Oxycodone/naloxone (Primary)
- Indications Constipation; Interstitial cystitis; Pain; Restless legs syndrome
- Focus Pharmacokinetics
- 17 Sep 2018 New trial record
- 05 Sep 2018 Results published in the Nephrology Dialysis Transplantation